{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T08:37:16Z","timestamp":1789115836853,"version":"build-2803163510"},"reference-count":87,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Genet."],"abstract":"<jats:p>\n                    Cancer vaccines have emerged as a promising strategy for personalized cancer immunotherapy; however, their development has traditionally relied on bulk sequencing approaches that average molecular information across millions of cells, thereby obscuring the extensive intratumoral heterogeneity that drives disease progression, therapeutic resistance, and immune escape. Recent advances in multi-modal single-cell genomics have transformed the ability to characterize tumors at unprecedented resolution, enabling the identification of distinct cellular populations, clonal evolutionary trajectories, and complex tumor-immune interactions. In parallel, artificial intelligence (AI) has rapidly expanded the capabilities of reverse vaccinology by facilitating large-scale analysis of genomic and immunological datasets for neoantigen discovery and vaccine design. This review aims to present a unique conceptual framework for future personalized cancer immunotherapies, rather than simply integrating the already established approaches. The framework is built on two levels: (1) filtering of false-positive targets using multi-modal single cell data and removing antigen loss clones; and (2) feeding the resulting rigorously filtered data into advanced structural and generative AI models to inform\n                    <jats:italic>de novo<\/jats:italic>\n                    design of multi-epitope vaccines. Particular emphasis is placed on the application of deep learning, graph neural networks, transformer architectures, and generative AI models for data preprocessing, clonal evolution analysis, immune microenvironment characterization, neoantigen prioritization, and peptide\u2013major histocompatibility complex (MHC) interaction prediction. Furthermore, we discuss the development of integrated computational pipelines capable of translating high-resolution multi-modal single-cell data into personalized multi-epitope cancer vaccines. Finally, we highlight the major translational challenges, including model interpretability, tumor plasticity, manufacturing constraints, and clinical implementation. By integrating multi-modal single-cell genomics with advanced AI methodologies, reverse vaccinology is poised to accelerate the development of highly targeted, adaptive, and durable cancer vaccines, offering a promising roadmap for the future of personalized cancer immunotherapy.\n                  <\/jats:p>","DOI":"10.3389\/fgene.2026.1909167","type":"journal-article","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T07:52:20Z","timestamp":1789113140000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["AI-driven genotype-phenotype modeling: a framework integrating multi-modal single-cell genomics and reverse vaccinology for de novo design of multi-epitope cancer vaccines"],"prefix":"10.3389","volume":"17","author":[{"given":"Mahabub","family":"Mallik","sequence":"first","affiliation":[{"name":"Department of Data Science, The West Bengal National University of Judicial Science","place":["Kolkata, West Bengal, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahid Afrid","family":"Mollick","sequence":"additional","affiliation":[{"name":"Anthropological Survey of India, Head Office","place":["Kolkata, West Bengal, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.3390\/cancers17132163","article-title":"Exploring experimental models of colorectal cancer: a critical appraisal from 2D cell systems to organoids, humanized mouse avatars, Organ-on-Chip, CRISPR engineering, and AI-Driven platforms\u2014challenges and opportunities for translational precision oncology","volume":"17","author":"Al-Kabani","year":"2025","journal-title":"Cancers"},{"key":"B2","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/nrg.2016.86","article-title":"Towards precision medicine","volume":"17","author":"Ashley","year":"2016","journal-title":"Nat. Rev. Genet."},{"key":"B3","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/nrc.2017.58","article-title":"Unravelling biology and shifting paradigms in cancer with single-cell sequencing","volume":"17","author":"Baslan","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"B4","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/s41746-020-00324-0","article-title":"The state of artificial intelligence-based FDA-Approved medical devices and algorithms: an online database","volume":"3","author":"Benjamens","year":"2020","journal-title":"Npj Digit. Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"588221","DOI":"10.3389\/fonc.2020.588221","article-title":"Artificial intelligence (AI)-based systems biology approaches in multi-omics data analysis of cancer","volume":"10","author":"Biswas","year":"2020","journal-title":"Front. Oncol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13073-019-0701-3","article-title":"Digital twins to personalize medicine","volume":"12","author":"Bj\u00f6rnsson","year":"2019","journal-title":"Genome Medicine"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1394003","DOI":"10.3389\/fimmu.2024.1394003","article-title":"Artificial intelligence and neoantigens: paving the path for precision cancer immunotherapy","volume":"15","author":"Bulashevska","year":"2024","journal-title":"Front. Immunol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/nbt.4313","article-title":"Deep learning using tumor HLA peptide mass spectrometry datasets improves neoantigen identification","volume":"37","author":"Bulik-Sullivan","year":"2018","journal-title":"Nat. Biotechnol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/s41587-021-01070-8","article-title":"Improved prediction of immune checkpoint blockade efficacy across multiple cancer types","volume":"40","author":"Chowell","year":"2021","journal-title":"Nat. Biotechnol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s12920-020-0694-1","article-title":"neoANT-HILL: an integrated tool for identification of potential neoantigens","volume":"13","author":"Coelho","year":"2020","journal-title":"BMC Med. Genomics"},{"key":"B11","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/s42256-025-01007-9","article-title":"Transformers and genome language models","volume":"7","author":"Consens","year":"2025","journal-title":"Nat. Mach. Intell."},{"key":"B12","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/s43586-024-00294-7","article-title":"Graph neural networks","volume":"4","author":"Corso","year":"2024","journal-title":"Nat. Rev. Methods Prim."},{"key":"B13","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/nrclinonc.2017.166","article-title":"Tumour heterogeneity and resistance to cancer therapies","volume":"15","author":"Dagogo-Jack","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"B14","doi-asserted-by":"crossref","DOI":"10.1007\/978-981-95-6845-1_24","article-title":"Potential breakthroughs and future research directions","volume-title":"Personalized Cancer Therapy","author":"Das","year":"2026"},{"key":"B15","doi-asserted-by":"publisher","first-page":"20746","DOI":"10.1021\/acsomega.0c00442","article-title":"Variational autoencoder for generation of antimicrobial peptides","volume":"5","author":"Dean","year":"2020","journal-title":"ACS Omega"},{"key":"B16","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1586\/erv.09.67","article-title":"Next-generation sequencing: a transformative tool for vaccinology","volume":"8","author":"Dhiman","year":"2009","journal-title":"Expert Rev. Vaccines"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1093\/biolre\/ioag011","article-title":"The evolution of endometriosis research models: a paradigm shift from immortalized cell lines to organoids","volume":"114","author":"Fang","year":"","journal-title":"Biol. Reproduction"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/ijo.2025.5749","article-title":"Strategies for neoantigen screening and immunogenicity validation in cancer immunotherapy","volume":"66","author":"Feng","year":"2025","journal-title":"Int. J. Oncol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/nrg.2015.16","article-title":"Single-cell genome sequencing: current state of the science","volume":"17","author":"Gawad","year":"2016","journal-title":"Nat. Rev. Genet."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1001\/jamainternmed.2018.3763","article-title":"Potential biases in machine learning algorithms using electronic health record data","volume":"178","author":"Gianfrancesco","year":"2018","journal-title":"JAMA Intern. Med."},{"key":"B21","doi-asserted-by":"publisher","first-page":"16189","DOI":"10.1038\/s41598-018-34533-1","article-title":"Design of metalloproteins and novel protein folds using variational autoencoders","volume":"8","author":"Greener","year":"2018","journal-title":"Sci. Rep."},{"key":"B22","doi-asserted-by":"publisher","first-page":"nwaf028","DOI":"10.1093\/nsr\/nwaf028","article-title":"Foundation models in bioinformatics","volume":"12","author":"Guo","year":"2025","journal-title":"Natl. Sci. Rev."},{"key":"B23","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.cd-21-1059","article-title":"Hallmarks of cancer: new dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discov."},{"key":"B24","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s13059-017-1215-1","article-title":"Multi-omics approaches to disease","volume":"18","author":"Hasin","year":"2017","journal-title":"Genome Biol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1093\/biostatistics\/kxx053","article-title":"Missing data and technical variability in single-cell RNA-Sequencing experiments","volume":"19","author":"Hicks","year":"2017","journal-title":"Biostatistics"},{"key":"B26","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.jtcme.2025.02.009","article-title":"A review of recent artificial intelligence for traditional medicine","volume":"15","author":"Hou","year":"2025","journal-title":"J. Traditional Complementary Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"20250077","DOI":"10.1002\/viw.20250077","article-title":"Unveiling large multimodal models in pulmonary CT: a comparative assessment of generative AI performance in lung cancer diagnostics","volume":"6","author":"Huang","year":"2025","journal-title":"View"},{"key":"B28","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1158\/2326-6066.CIR-19-0401","article-title":"pVACtools: a computational toolkit to identify and visualize cancer neoantigens","volume":"8","author":"Hundal","year":"2020","journal-title":"Cancer Immunology Research"},{"key":"B29","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly accurate protein structure prediction with AlphaFold","volume":"596","author":"Jumper","year":"2021","journal-title":"Nature"},{"key":"B30","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/s41577-023-00937-y","article-title":"Challenges in developing personalized neoantigen cancer vaccines","volume":"24","author":"Katsikis","year":"2023","journal-title":"Nat. Rev. Immunol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/978-1-0716-0327-7_10","article-title":"OpenVaX: an open-source computational pipeline for cancer neoantigen prediction","volume":"2120","author":"Kodysh","year":"2020","journal-title":"Methods Molecular Biology"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1038\/s44222-025-00349-8","article-title":"AI-driven protein design","volume":"3","author":"Koh","year":"2025","journal-title":"Nat. Rev. Bioeng."},{"key":"B33","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3390\/biochem5020005","article-title":"Advances in personalized cancer vaccine development: AI applications from neoantigen discovery to mRNA formulation","volume":"5","author":"Kong","year":"2025","journal-title":"Biochem."},{"key":"B34","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1142\/s2339547818300020","article-title":"The growing role of precision and personalized medicine for cancer treatment","volume":"6","author":"Krzyszczyk","year":"2018","journal-title":"TECHNOLOGY"},{"key":"B35","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.bbcan.2017.02.001","article-title":"Advances in understanding tumour evolution through single-cell sequencing","volume":"1867","author":"Kuipers","year":"2017","journal-title":"Biochimica Biophysica Acta (BBA) - Rev. Cancer"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1357217","DOI":"10.3389\/fimmu.2024.1357217","article-title":"Personalized cancer vaccine design using AI-powered technologies","volume":"15","author":"Kumar","year":"2024","journal-title":"Front. Immunol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s13059-020-1926-6","article-title":"Eleven grand challenges in single-cell data science","volume":"21","author":"L\u00e4hnemann","year":"2020","journal-title":"Genome Biol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1186\/s12943-025-02426-3","article-title":"Single-cell multi-omics in cancer immunotherapy: from tumor heterogeneity to personalized precision treatment","volume":"24","author":"Le","year":"2025","journal-title":"Mol. Cancer"},{"key":"B39","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1021\/acs.jproteome.5c00506","article-title":"Protein language models: applications and perspectives","volume":"25","author":"Leclercq","year":"2025","journal-title":"J. Proteome Res."},{"key":"B40","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1021\/acs.jcim.1c01361","article-title":"De novo Peptide and protein design using Generative Adversarial Networks: an update","volume":"62","author":"Lin","year":"2022","journal-title":"J. Chem. Inf. Model."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1656012","DOI":"10.3389\/fphar.2025.1656012","article-title":"Strategies for the drug development of cancer therapeutics","volume":"16","author":"Liu","year":"","journal-title":"Front. Pharmacol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"105706","DOI":"10.1016\/j.ebiom.2025.105706","article-title":"Serum metabolic fingerprints encode functional biomarkers for ovarian cancer diagnosis: a large-scale cohort study","volume":"115","author":"Liu","year":"","journal-title":"EBioMedicine"},{"key":"B43","doi-asserted-by":"publisher","first-page":"20230043","DOI":"10.1515\/jib-2023-0043","article-title":"Transformers meets neoantigen detection: a systematic literature review","volume":"21","author":"Machaca","year":"2024","journal-title":"Berichte Aus Der Medizinischen Inf. Und Bioinformatik\/Journal Integr. Bioinforma."},{"key":"B44","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3390\/organoids4040023","article-title":"Organoids as next-generation models for tumor heterogeneity, personalized therapy, and cancer research: advancements, applications, and future directions","volume":"4","author":"Madan","year":"2025","journal-title":"Organoids"},{"key":"B45","doi-asserted-by":"publisher","first-page":"bbag229","DOI":"10.1093\/bib\/bbag229","article-title":"Artificial intelligence in genomics: a comprehensive survey of methods, resources, challenges, and prospects","volume":"27","author":"Mahmud","year":"2026","journal-title":"Briefings Bioinforma."},{"key":"B46","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.cell.2017.01.018","article-title":"Clonal heterogeneity and tumor evolution: past, present, and the future","volume":"168","author":"McGranahan","year":"2017","journal-title":"Cell"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1093\/bib\/bbz051","article-title":"A comprehensive review and performance evaluation of bioinformatics tools for HLA class I peptide-binding prediction","volume":"21","author":"Mei","year":"2019","journal-title":"Briefings Bioinforma."},{"key":"B48","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/nature09807","article-title":"Tumour evolution inferred by single-cell sequencing","volume":"472","author":"Navin","year":"2011","journal-title":"Nature"},{"key":"B49","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.trecan.2025.08.013","article-title":"Advancing human leukocyte antigen-based cancer immunotherapy: from personalized to broad-spectrum strategies for genetically heterogeneous populations","volume":"11","author":"Oseni","year":"2025","journal-title":"Trends Cancer"},{"key":"B50","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/nature22991","article-title":"An immunogenic personal neoantigen vaccine for patients with melanoma","volume":"547","author":"Ott","year":"2017","journal-title":"Nature"},{"key":"B51","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1007\/s10142-024-01417-9","article-title":"The impact and future of artificial intelligence in medical genetics and molecular medicine: an ongoing revolution","volume":"24","author":"Ozcelik","year":"2024","journal-title":"Funct. and Integr. Genomics"},{"key":"B52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1146\/annurev-biodatasci-092724-043507","article-title":"Precision Oncology: multimodal and multiscale methods to promote mechanistic understanding","volume":"9","author":"Ozturk","year":"2026","journal-title":"Annu. Rev. Biomed. Data Sci."},{"key":"B53","doi-asserted-by":"publisher","first-page":"e1012511","DOI":"10.1371\/journal.pcbi.1012511","article-title":"A modular protein language modelling approach to immunogenicity prediction","volume":"20","author":"O\u2019Brien","year":"2024","journal-title":"PLoS Comput. Biol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/nri.2017.76","article-title":"Single-cell RNA sequencing to explore immune cell heterogeneity","volume":"18","author":"Papalexi","year":"2017","journal-title":"Nat. Rev. Immunol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"e70061","DOI":"10.1002\/jgm.70061","article-title":"Artificial intelligence for predictive modeling in CRISPR\/Cas9 Gene Editing: a Survey of methods and design strategies","volume":"27","author":"Patel","year":"2025","journal-title":"J. Gene Med."},{"key":"B56","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s10238-025-01902-w","article-title":"Beyond single biomarkers: multi-omics strategies to predict immunotherapy outcomes in blood cancers","volume":"25","author":"Pirouzbakht","year":"2025","journal-title":"Clin. Exp. Med."},{"key":"B57","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/s1369-5274(00)00119-3","article-title":"Reverse vaccinology","volume":"3","author":"Rappuoli","year":"2000","journal-title":"Curr. Opin. Microbiol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1126\/science.aar4060","article-title":"Cancer immunotherapy using checkpoint blockade","volume":"359","author":"Ribas","year":"2018","journal-title":"Science"},{"key":"B59","doi-asserted-by":"publisher","first-page":"e2016239118","DOI":"10.1073\/pnas.2016239118","article-title":"Biological structure and function emerge from scaling unsupervised learning to 250 million protein sequences","volume":"118","author":"Rives","year":"2021","journal-title":"Proc. Natl. Acad. Sci."},{"key":"B60","doi-asserted-by":"publisher","first-page":"142919","DOI":"10.1101\/142919","article-title":"Vaxrank: a computational tool for designing personalized cancer vaccines","author":"Rubinsteyn","year":"2018","journal-title":"bioRxiv"},{"key":"B61","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/nature23003","article-title":"Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer","volume":"547","author":"Sahin","year":"2017","journal-title":"Nature"},{"key":"B62","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1038\/s41568-021-00346-0","article-title":"Therapeutic cancer vaccines","volume":"21","author":"Saxena","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"B63","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1186\/s12859-019-2876-4","article-title":"NeoPredPipe: high-throughput neoantigen prediction and recognition potential pipeline","volume":"20","author":"Schenck","year":"2019","journal-title":"BMC Bioinforma."},{"key":"B64","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1126\/science.aaa4971","article-title":"Neoantigens in cancer immunotherapy","volume":"348","author":"Schumacher","year":"2015","journal-title":"Science"},{"key":"B65","doi-asserted-by":"publisher","first-page":"e48316","DOI":"10.15252\/embr.201948316","article-title":"Re\u2010identifiability of genomic data and the GDPR","volume":"20","author":"Shabani","year":"2019","journal-title":"EMBO Rep."},{"key":"B66","doi-asserted-by":"publisher","first-page":"101743","DOI":"10.1016\/j.imu.2026.101743","article-title":"Systematic review of transformers, graph neural networks, and federated learning in oncology: applications, challenges, and pathways to clinical translation","volume":"61","author":"Shafiei","year":"2026","journal-title":"Inf. Med. Unlocked"},{"key":"B67","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/978-1-0716-4690-8_21","article-title":"The use of AI for phenotype-genotype mapping","volume":"2952","author":"Sharma","year":"2025","journal-title":"Methods Mol. Biol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"e70080","DOI":"10.1002\/bies.70080","article-title":"Zebrafish: a versatile and powerful model for biomedical research","volume":"47","author":"Siddiqui","year":"2025","journal-title":"BioEssays"},{"key":"B69","doi-asserted-by":"publisher","first-page":"1469329","DOI":"10.3389\/fimmu.2024.1469329","article-title":"Advancements in Mammalian display technology for therapeutic antibody development and beyond: current landscape, challenges, and future prospects","volume":"15","author":"Slavny","year":"2024","journal-title":"Front. Immunol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"100365","DOI":"10.1016\/j.ibmed.2026.100365","article-title":"AI-driven genomic medicine: a comprehensive review of clinical applications, institutional dynamics, and governance challenges","volume":"14","author":"Souleiman","year":"2026","journal-title":"Intelligence-Based Med."},{"key":"B71","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/s41576-019-0093-7","article-title":"Integrative single-cell analysis","volume":"20","author":"Stuart","year":"2019","journal-title":"Nat. Rev. Genet."},{"key":"B72","doi-asserted-by":"publisher","first-page":"102238","DOI":"10.1016\/j.xcrm.2025.102238","article-title":"Metabolic fingerprinting enables rapid, label-free histopathology in gastric cancer diagnosis and prognostic prediction","volume":"6","author":"Teng","year":"2025","journal-title":"Cell Rep. Med."},{"key":"B73","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s13073-022-01138-3","article-title":"Therapy sculpts the complex interplay between cancer and the immune system during tumour evolution","volume":"14","author":"Thol","year":"2022","journal-title":"Genome Med."},{"key":"B74","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/s41591-018-0300-7","article-title":"High-performance medicine: the convergence of human and artificial intelligence","volume":"25","author":"Topol","year":"2018","journal-title":"Nat. Med."},{"key":"B75","doi-asserted-by":"publisher","first-page":"22847","DOI":"10.1021\/acsomega.0c02088","article-title":"Generating ampicillin-level antimicrobial peptides with activity-aware generative adversarial networks","volume":"5","author":"Tucs","year":"2020","journal-title":"ACS Omega"},{"key":"B76","doi-asserted-by":"publisher","first-page":"100766","DOI":"10.1016\/j.nantod.2019.100766","article-title":"Three decades of messenger RNA vaccine development","volume":"28","author":"Verbeke","year":"2019","journal-title":"Nano Today"},{"key":"B77","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/s41541-025-01258-y","article-title":"AI-driven epitope prediction: a systematic review, comparative analysis, and practical guide for vaccine development","volume":"10","author":"Villanueva-Flores","year":"2025","journal-title":"Npj Vaccines"},{"key":"B78","doi-asserted-by":"publisher","first-page":"667","DOI":"10.3390\/genes16060667","article-title":"Advances in genitourinary tumor genomics and immunotherapy","volume":"16","author":"Vohra","year":"2025","journal-title":"Genes"},{"key":"B79","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/nrc.2017.7","article-title":"Liquid biopsies come of age: towards implementation of circulating tumour DNA","volume":"17","author":"Wan","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"B80","doi-asserted-by":"publisher","first-page":"2826","DOI":"10.4251\/wjgo.v16.i6.2826","article-title":"Visualization analysis of research hotspots and trends on gastrointestinal tumor organoids","volume":"16","author":"Wang","year":"2024","journal-title":"World J. Gastrointest. Oncol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"20240145","DOI":"10.1002\/viw.20240145","article-title":"Circulating genomic biomarkers predict chemoradiotherapy resistance and immunotherapy response in locally advanced non\u2010small\u2010cell lung cancer","volume":"6","author":"Wang","year":"2025","journal-title":"View"},{"key":"B82","doi-asserted-by":"publisher","first-page":"e70096","DOI":"10.1002\/imo2.70096","article-title":"Progress of metabolomics\u2010centric multi\u2010omics research in medicine","volume":"3","author":"Wang","year":"2026","journal-title":"iMetaOmics"},{"key":"B83","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/j.cell.2020.09.015","article-title":"Key parameters of tumor epitope immunogenicity revealed through a consortium approach improve neoantigen prediction","volume":"183","author":"Wells","year":"2020","journal-title":"Cell"},{"key":"B84","doi-asserted-by":"publisher","first-page":"102794","DOI":"10.1016\/j.sbi.2024.102794","article-title":"Generative artificial intelligence for de novo protein design","volume":"86","author":"Winnifrith","year":"2024","journal-title":"Curr. Opin. Struct. Biol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.csbj.2024.12.030","article-title":"AI-driven multi-omics integration for multi-scale predictive modeling of causal genotype-environment-phenotype relationships","volume":"27","author":"Wu","year":"2025","journal-title":"Comput. Struct. Biotech. J."},{"key":"B86","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1038\/nature14001","article-title":"Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing","volume":"515","author":"Yadav","year":"2014","journal-title":"Nature"},{"key":"B87","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/s41586-018-0694-x","article-title":"Lineage tracking reveals dynamic relationships of T cells in colorectal cancer","volume":"564","author":"Zhang","year":"2018","journal-title":"Nature"}],"container-title":["Frontiers in Genetics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2026.1909167\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T07:52:22Z","timestamp":1789113142000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2026.1909167\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,11]]},"references-count":87,"alternative-id":["10.3389\/fgene.2026.1909167"],"URL":"https:\/\/doi.org\/10.3389\/fgene.2026.1909167","relation":{},"ISSN":["1664-8021"],"issn-type":[{"value":"1664-8021","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,11]]},"article-number":"1909167"}}